Literature DB >> 20488537

Cultivating hepatocytes on printed arrays of HGF and BMP7 to characterize protective effects of these growth factors during in vitro alcohol injury.

Caroline N Jones1, Nazgul Tuleuova, Ji Youn Lee, Erlan Ramanculov, A Hari Reddi, Mark A Zern, Alexander Revzin.   

Abstract

The goal of the present study was to investigate hepato-protective effects of growth factor (GF) arrays during alcohol injury. Hepatocyte growth factor (HGF) and bone morphogenetic protein (BMP)7 were mixed with collagen (I) and robotically printed onto standard glass slides to create arrays of 500 microm diameter spots. Primary rat hepatocytes were seeded on top of the arrays forming clusters corresponding in size to the underlying protein spots. Cell arrays were then injured in culture by exposure to 100 mm ethanol for 48 h. Hepatocytes residing on GF spots were found to have less apoptosis then cells cultured on collagen-only spots. Least apoptosis (0.3% as estimated by TUNEL assay) was observed on HGF/BMP7/collagen spots whereas most apoptosis (17.3%) was seen on collagen-only arrays. Interestingly, the extent of alcohol-induced apoptosis in hepatocytes varied based on the concentration of printed GF. In addition to preventing apoptosis, printed GFs contributed to maintenance of epithelial phenotype during alcohol injury as evidenced by higher levels of E-cadherin expression in HGF-protected hepatocytes. Importantly, GF microarrays could be used to investigate heterotypic interactions in the context of liver injury. To highlight this, stellate cells - nonparenchymal liver cells involved in fibrosis - were added to hepatocytes residing on arrays of either HGF/collagen or collagen-only spots. Exposure of these cocultures to ethanol followed by RT-PCR analysis revealed that stellate cells residing alongside HGF-protected hepatocytes were significantly less activated (less fibrotic) compared to controls. Overall, our results demonstrate that GF microarray format can be used to screen anti-fibrotic and anti-apoptotic effects of growth factors as well as to investigate how signals delivered to a specific cell type modulate heterotypic cellular interactions. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488537      PMCID: PMC2893270          DOI: 10.1016/j.biomaterials.2010.04.006

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  45 in total

1.  Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis.

Authors:  J Zhu; J Wu; E Frizell; S L Liu; R Bashey; R Rubin; P Norton; M A Zern
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

2.  BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways.

Authors:  T D Piscione; T Phan; N D Rosenblum
Journal:  Am J Physiol Renal Physiol       Date:  2001-01

3.  Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells.

Authors:  B K Mann; R H Schmedlen; J L West
Journal:  Biomaterials       Date:  2001-03       Impact factor: 12.479

4.  Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.

Authors:  T Nakamura; R Sakata; T Ueno; M Sata; H Ueno
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

Review 5.  Apoptosis in diseases of the liver.

Authors:  M G Neuman
Journal:  Crit Rev Clin Lab Sci       Date:  2001-04       Impact factor: 6.250

6.  HGF suppresses the production of collagen type III and alpha-SMA induced by TGF-beta1 in healing fibroblasts.

Authors:  Dapeng Jiang; Zhitao Jiang; Fuyou Han; Yubo Zhang; Zhaozhu Li
Journal:  Eur J Appl Physiol       Date:  2008-04-02       Impact factor: 3.078

7.  BMP-7 and proximal tubule epithelial cells: activation of multiple signaling pathways reveals a novel anti-fibrotic mechanism.

Authors:  Reza Motazed; Paul Colville-Nash; Jonathan T C Kwan; Mark E C Dockrell
Journal:  Pharm Res       Date:  2008-02-21       Impact factor: 4.200

8.  Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes.

Authors:  Masayuki Nishino; Yuji Iimuro; Takahiro Ueki; Tadamichi Hirano; Jiro Fujimoto
Journal:  Surgery       Date:  2008-07-10       Impact factor: 3.982

9.  Functional immobilization of signaling proteins enables control of stem cell fate.

Authors:  Kristin Alberti; Ryan E Davey; Kento Onishi; Sophia George; Katrin Salchert; F Philipp Seib; Martin Bornhäuser; Tilo Pompe; Andras Nagy; Carsten Werner; Peter W Zandstra
Journal:  Nat Methods       Date:  2008-06-15       Impact factor: 28.547

10.  Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.

Authors:  G H Xiao; M Jeffers; A Bellacosa; Y Mitsuuchi; G F Vande Woude ; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  20 in total

Review 1.  Life on a microarray: assessing live cell functions in a microarray format.

Authors:  Krisztián Papp; Zoltán Szittner; József Prechl
Journal:  Cell Mol Life Sci       Date:  2012-03-04       Impact factor: 9.261

2.  Characterizing the effects of heparin gel stiffness on function of primary hepatocytes.

Authors:  Jungmok You; Su-A Park; Dong-Sik Shin; Dipali Patel; Vijay Krishna Raghunathan; Mihye Kim; Christopher J Murphy; Giyoong Tae; Alexander Revzin
Journal:  Tissue Eng Part A       Date:  2013-08-16       Impact factor: 3.845

3.  Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  Hiroki Tojima; Satoru Kakizaki; Takashi Kosone; Norio Horiguchi; Yuichi Yamazaki; Ken Sato; Hitoshi Takagi; Masatomo Mori
Journal:  Hepatol Int       Date:  2011-08-05       Impact factor: 6.047

4.  Using reconfigurable microfluidics to study the role of HGF in autocrine and paracrine signaling of hepatocytes.

Authors:  Dipali Patel; Amranul Haque; Yandong Gao; Alexander Revzin
Journal:  Integr Biol (Camb)       Date:  2015-07       Impact factor: 2.192

5.  Using growth factor arrays and micropatterned co-cultures to induce hepatic differentiation of embryonic stem cells.

Authors:  Nazgul Tuleuova; Ji Youn Lee; Jennifer Lee; Erlan Ramanculov; Mark A Zern; Alexander Revzin
Journal:  Biomaterials       Date:  2010-09-15       Impact factor: 12.479

6.  Bottom-up signaling from HGF-containing surfaces promotes hepatic differentiation of mesenchymal stem cells.

Authors:  Mahboobe Ghaedi; Nazgul Tuleuova; Mark A Zern; Jian Wu; Alexander Revzin
Journal:  Biochem Biophys Res Commun       Date:  2011-03-05       Impact factor: 3.575

7.  Harnessing endogenous signals from hepatocytes using a low volume multi-well plate.

Authors:  Pantea Gheibi; Kyung Jin Son; Gulnaz Stybayeva; Alexander Revzin
Journal:  Integr Biol (Camb)       Date:  2017-05-22       Impact factor: 2.192

8.  Local control of hepatic phenotype with growth factor-encoded surfaces.

Authors:  Dipali Patel; Amranul Haque; Caroline N Jones; Nazgul Tuleouva; Elena Foster; Tam Vu; A Hari Reddi; Alexander Revzin
Journal:  Integr Biol (Camb)       Date:  2014-01       Impact factor: 2.192

9.  Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury.

Authors:  Shuyong Wang; Xuan Wang; Zuolong Tan; Yuxin Su; Juan Liu; Mingyang Chang; Fang Yan; Jie Chen; Tao Chen; Chuanjiang Li; Jie Hu; Yunfang Wang
Journal:  Cell Res       Date:  2019-10-18       Impact factor: 25.617

10.  Microfluidic fabrication of bioactive microgels for rapid formation and enhanced differentiation of stem cell spheroids.

Authors:  Christian Siltanen; Maliheh Yaghoobi; Amranul Haque; Jungmok You; Jeremy Lowen; Masoud Soleimani; Alexander Revzin
Journal:  Acta Biomater       Date:  2016-01-13       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.